This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2006
Title: The Innovative Contributions of Piotr J Czernik
Introduction
Piotr J Czernik is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the field of cancer research through his innovative work on the human UDP-glucuronosyltransferase 2B7 (UGT2B7) protein. His research focuses on the potential applications of UGT2B7 in detecting and treating various cancers.
Latest Patents
Czernik holds a patent titled "Uses of human UDP-glucuronosyltransferase 2B7 to detect and treat cancer." This patent highlights the unique expression of UGT2B7 protein, which is limited to ovarian surface epithelium cells and absent in tumors arising from this cell layer. The research indicates that UGT2B7 protein accumulates in cells during stationary phase and growth inhibition, while it is not expressed in exponentially growing ovarian tumor cells. Overexpression of UGT2B7 in human ovarian tumor cells leads to cell growth arrest, a significant reduction in lipid content, and changes in cell morphology. This discovery suggests that active UGT2B7 protein expression can be utilized to decrease cell proliferation and treat various cancers. Furthermore, UGT2B7 mRNA expression, protein expression, and enzymatic activity can serve as tumor-specific markers in diagnostic procedures.
Career Highlights
Throughout his career, Czernik has focused on the intersection of biochemistry and oncology. His research has contributed to a deeper understanding of cancer biology and the potential for targeted therapies. His innovative approach to utilizing UGT2B7 in cancer treatment showcases his commitment to advancing medical science.
Collaborations
Czernik has collaborated with Anna Radominska-Pandya, a fellow researcher in the field. Their partnership has fostered advancements in understanding the role of UGT2B7 in cancer detection and treatment.
Conclusion
Piotr J Czernik's work exemplifies the impact of innovative research in the fight against cancer. His patent on UGT2B7 opens new avenues for diagnostic and therapeutic applications, highlighting the importance of continued research in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile